From: Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
Response
No. of Pts (%)
Histopathologic response
   Pathologic complete response
4 (5.1)
   Minimal residual disease
10 (12.8)
   Gross residual disease
64 (82.1)